Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Amplyx Pharmaceuticals, a clinical-stage biopharmaceutical company developing innovative therapies for debilitating and life-threatening diseases in...
Amplyx Pharmaceuticals, a biotech company developing innovative therapies for debilitating and life-threatening diseases in patients with compromised ...
Amplyx Pharmaceuticals, a clinical stage biotech company developing innovative therapies for debilitating and life-threatening diseases in patients...
Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients...
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, announced today that three posters from the...
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, announced today that the U.S. Food and Drug...
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, today announced that the first patient has been ...
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, today announced that Amplyx and its...
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, today announced that the company's president...
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, today announced that preclinical data...
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, including deadly fungal pathogens, today...
Amplyx Pharmaceuticals, a company developing first-in-class products for life-threatening infections, with a near-term focus on deadly fungal...
Amplyx Pharmaceuticals, a company developing novel antimicrobial agents for life-threatening fungal infections, today announced that it presented...
Amplyx Pharmaceuticals, a biotechnology company developing novel antimicrobial agents for life-threatening fungal infections, today announced that...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.